AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34432142 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin C serum levels
Number of subjects: 2035
Study 34432142 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin C serum levels in males
Number of subjects: 2035
Study 34432142 — intervention group
Group type: EXPERIMENTAL
Intervention: Cystatin C serum levels in females
Number of subjects: 2035
Study 34432155 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial plexus block (BPB)
Number of subjects: 5340
Study 34432155 — intervention group
Group type: EXPERIMENTAL
Intervention: Brachial plexus block (BPB) by supervised trainees
Number of subjects: 5340
Study 34432206 — intervention group
Group type: EXPERIMENTAL
Intervention: Jianpi Bushen Sequential Formula (JBSF)
Number of subjects: 400
Study 34432206 — intervention group
Group type: COMPARATOR
Intervention: Placebo formula
Number of subjects: 400
Study 34432541 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34432679 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of INR/(CHE*platelet count)
Number of subjects: 33
Study 34432679 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of MELD/(CHE*platelet count)
Number of subjects: 33
Study 34432679 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline MELD score, INR, CHE, and platelet counts
Number of subjects: 33
Study 34432811 — intervention group
Group type: EXPERIMENTAL
Intervention: Tumor mitotic volume and excessive lesion glycolysis for breast and lung cancer
Number of subjects: 0
Study 34432811 — intervention group
Group type: EXPERIMENTAL
Intervention: Surface area of tumors invading beyond the subserosa for colorectal cancer
Number of subjects: 0
Study 34432811 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical correlates of circulating tumor fraction
Number of subjects: 0
Study 34432828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher socioeconomic status (SES)
Number of subjects: 279
Study 34432828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher income
Number of subjects: 279
Study 34432828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher SES indicators (car ownership)
Number of subjects: 279
Study 34432828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher SES indicators (television ownership)
Number of subjects: 279
Study 34432828 — intervention group
Group type: EXPERIMENTAL
Intervention: Higher SES indicators (electricity access)
Number of subjects: 279
Study 34432828 — intervention group
Group type: COMPARATOR
Intervention: No education
Number of subjects: 279
Study 34432828 — intervention group
Group type: COMPARATOR
Intervention: Lower income
Number of subjects: 279
Study 34432828 — intervention group
Group type: EXPERIMENTAL
Intervention: Water kiosk use
Number of subjects: 279
Study 34432850 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month complex lifestyle intervention (two 1-hour group sessions per week with instructor-led exercise and three 2-hour group counselling sessions)
Number of subjects: 16
Study 34432850 — intervention group
Group type: EXPERIMENTAL
Intervention: 6-month complex lifestyle intervention
Number of subjects: 16
Study 34432863 — intervention group
Group type: EXPERIMENTAL
Intervention: Tisagenlecleucel
Number of subjects: 258
Study 34432870 — intervention group
Group type: EXPERIMENTAL
Intervention: m-EASIX (modified EASIX)
Number of subjects: 118
Study 34432870 — intervention group
Group type: EXPERIMENTAL
Intervention: m-EASIX
Number of subjects: 118
Study 34432870 — intervention group
Group type: COMPARATOR
Intervention: m-EASIX, simplified EASIX, EASIX
Number of subjects: 118
Study 34432870 — intervention group
Group type: EXPERIMENTAL
Intervention: Low PLTs and high CRP
Number of subjects: 118
Study 34432869 — intervention group
Group type: EXPERIMENTAL
Intervention: Tolerance conditioning regimen (total lymphoid irradiation, anti-thymocyte globulin conditioning, donor hematopoietic cell transplant)
Number of subjects: 0
Study 34432869 — intervention group
Group type: EXPERIMENTAL
Intervention: Posttransplant pmn MDSCs
Number of subjects: 0
Study 34432874 — intervention group
Group type: EXPERIMENTAL
Intervention: Next-generation sequencing (NGS) based monitoring of circulating tumor DNA (ctDNA)
Number of subjects: 45
Study 34433298 — intervention group
Group type: EXPERIMENTAL
Intervention: Atorvastatin 40 mg daily
Number of subjects: 75
Study 34433304 — intervention group
Group type: EXPERIMENTAL
Intervention: Robot-assisted laparoscopic prostatectomy (RALP)
Number of subjects: 1094
Study 34433304 — intervention group
Group type: COMPARATOR
Intervention: Open radical prostatectomy (ORP)
Number of subjects: 1094
Study 34433303 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-102 (6 once-weekly instillations)
Number of subjects: 63
Study 34433303 — intervention group
Group type: EXPERIMENTAL
Intervention: UGN-102
Number of subjects: 63
Study 34433309 — intervention group
Group type: EXPERIMENTAL
Intervention: First-pass effect (FPE) achieved in 93 patients (33.2%)
Number of subjects: 280
Study 34433309 — intervention group
Group type: EXPERIMENTAL
Intervention: First-pass effect (FPE)
Number of subjects: 280
Study 34433309 — intervention group
Group type: EXPERIMENTAL
Intervention: Contact aspiration as first-line strategy
Number of subjects: 280
Study 34433309 — intervention group
Group type: EXPERIMENTAL
Intervention: Baseline antiplatelets and atheromatous etiology
Number of subjects: 280
Study 34433344 — intervention group
Group type: EXPERIMENTAL
Intervention: Low to moderate CCI with MCC
Number of subjects: 0
Study 34433344 — intervention group
Group type: EXPERIMENTAL
Intervention: High CCI with MCC
Number of subjects: 0
Study 34433344 — intervention group
Group type: EXPERIMENTAL
Intervention: High CCI and metastatic cancer
Number of subjects: 0
Study 34433359 — intervention group
Group type: EXPERIMENTAL
Intervention: SitLess with MS intervention
Number of subjects: 41
Study 34433476 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical activity guidelines at 1 year of age
Number of subjects: 528
Study 34433476 — intervention group
Group type: EXPERIMENTAL
Intervention: Sleeping for 11-14 hours or having consistent wake and sleep times at 1 year of age
Number of subjects: 528
Study 34433476 — intervention group
Group type: EXPERIMENTAL
Intervention: Screen time guidelines at 5 years of age
Number of subjects: 528
Study 34433476 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to all three guidelines at 1 year of age
Number of subjects: 528
Study 34433476 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence to all three guidelines at 5 years of age
Number of subjects: 528
Study 34433481 — intervention group
Group type: EXPERIMENTAL
Intervention: NfL-based prediction model
Number of subjects: 125
Study 34433481 — intervention group
Group type: COMPARATOR
Intervention: Lead-in approach
Number of subjects: 125
Study 34433481 — intervention group
Group type: COMPARATOR
Intervention: ΔFRS-based approach
Number of subjects: 125
Study 34433549 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone intravitreal implant 0.7 mg (DEX; Ozurdex)
Number of subjects: 57
Study 34433593 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural treatment for childhood insomnia (CBT-CI) adapted for children with ASD (in-person or remote)
Number of subjects: 180
Study 34433593 — intervention group
Group type: COMPARATOR
Intervention: Sleep Hygiene and Related Education
Number of subjects: 180
Study 34433593 — intervention group
Group type: COMPARATOR
Intervention: CBT-CI and Sleep Hygiene Education
Number of subjects: 180
Study 34433608 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month dietary intervention delivered via face-to-face motivational interviews, fortnightly motivational phone calls, monthly electronic pamphlets, quarterly newsletters and quarterly group meetings.
Number of subjects: 55
Study 34433608 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-month dietary intervention
Number of subjects: 55
Study 34433633 — intervention group
Group type: EXPERIMENTAL
Intervention: WT1-sensitized T cells dosed at 5×10
Number of subjects: 12
Study 34433633 — intervention group
Group type: EXPERIMENTAL
Intervention: WT1-sensitized T cells
Number of subjects: 12
Study 34433649 — intervention group
Group type: EXPERIMENTAL
Intervention: Tafasitamab + Lenalidomide
Number of subjects: 76
Study 34433649 — intervention group
Group type: COMPARATOR
Intervention: Lenalidomide Monotherapy
Number of subjects: 76
Study 34433648 — intervention group
Group type: EXPERIMENTAL
Intervention: LSZ102 alone (arm A)
Number of subjects: 198
Study 34433648 — intervention group
Group type: EXPERIMENTAL
Intervention: LSZ102 with ribociclib (arm B)
Number of subjects: 198
Study 34433648 — intervention group
Group type: EXPERIMENTAL
Intervention: LSZ102 with alpelisib (arm C)
Number of subjects: 198
Study 34433780 — intervention group
Group type: EXPERIMENTAL
Intervention: AI-assisted automatic cataract grading program based on LOCS III
Number of subjects: 0
Study 34434256 — intervention group
Group type: EXPERIMENTAL
Intervention: 4F-FPS (Flow diversion Predictive Score)
Number of subjects: 662
Study 34434256 — intervention group
Group type: EXPERIMENTAL
Intervention: Derivation group
Number of subjects: 662
Study 34434256 — intervention group
Group type: EXPERIMENTAL
Intervention: Validation group
Number of subjects: 662
Study 34434565 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypofractionated radiotherapy (34 Gy/10#/2 weeks + 10 Gy/5#/1 wk for BCS patients)
Number of subjects: 50
Study 34435165 — intervention group
Group type: EXPERIMENTAL
Intervention: Gum-chewing added to conventional postoperative feeding regimen
Number of subjects: 0
Study 34435395 — intervention group
Group type: EXPERIMENTAL
Intervention: BEO (bergamot essential oil) cream (80 mg) applied trans-dermally twice a day for 4 weeks
Number of subjects: 134
Study 34435395 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream applied trans-dermally twice a day for 4 weeks
Number of subjects: 134
Study 34435403 — intervention group
Group type: EXPERIMENTAL
Intervention: High adherence to integrative oncology (AIC)
Number of subjects: 439
Study 34435432 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 34435552 — intervention group
Group type: EXPERIMENTAL
Intervention: Early PET/CT scans on days 4 (D4) and 21 (D21) of cycle 1 (C1) of salvage therapy
Number of subjects: 25
Study 34435552 — intervention group
Group type: EXPERIMENTAL
Intervention: Early PET/CT response at D4 or D21
Number of subjects: 25
Study 34435552 — intervention group
Group type: EXPERIMENTAL
Intervention: Persistent response on both D4 and D21
Number of subjects: 25
Study 34435684 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral alisertib 45 to 100 mg/m²
Number of subjects: 0
Study 34435699 — intervention group
Group type: EXPERIMENTAL
Intervention: Sipuleucel-T
Number of subjects: 0
Study 34435699 — intervention group
Group type: EXPERIMENTAL
Intervention: Pembrolizumab
Number of subjects: 0
Study 34435897 — intervention group
Group type: EXPERIMENTAL
Intervention: Pregnancy and lactation
Number of subjects: 0
Study 34435897 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical treatments affecting bone metabolism
Number of subjects: 0
Study 34435960 — intervention group
Group type: EXPERIMENTAL
Intervention: Previsit patient important issue questionnaire
Number of subjects: 34037
Study 34435960 — intervention group
Group type: EXPERIMENTAL
Intervention: EHR tools for patient engagement
Number of subjects: 34037
Study 34435962 — intervention group
Group type: EXPERIMENTAL
Intervention: OTS mat condition (seated players)
Number of subjects: 78
Study 34435962 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted mat condition
Number of subjects: 78
Study 34435962 — intervention group
Group type: COMPARATOR
Intervention: OTS mat condition (standing players)
Number of subjects: 78
Study 34435968 — intervention group
Group type: EXPERIMENTAL
Intervention: Medimoov exergame platform
Number of subjects: 50
Study 34435968 — intervention group
Group type: COMPARATOR
Intervention: Standard psychomotor rehabilitation
Number of subjects: 50
Study 34435971 — intervention group
Group type: EXPERIMENTAL
Intervention: Website-only intervention
Number of subjects: 66
Study 34435971 — intervention group
Group type: EXPERIMENTAL
Intervention: Website-coaching intervention
Number of subjects: 66
Study 34435971 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 66
Study 34436569 — intervention group
Group type: EXPERIMENTAL
Intervention: ABX464 (150 mg daily for 4 weeks)
Number of subjects: 9
Study 34437304 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic retinopathy (DR)
Number of subjects: 87
Study 34437304 — intervention group
Group type: COMPARATOR
Intervention: No DR
Number of subjects: 87
Study 34437720 — intervention group
Group type: EXPERIMENTAL
Intervention: Dupilumab
Number of subjects: 0
Study 34437720 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34438022 — intervention group
Group type: EXPERIMENTAL
Intervention: Parent-reported irritability
Number of subjects: 195
Study 34438022 — intervention group
Group type: EXPERIMENTAL
Intervention: Child-reported anger
Number of subjects: 195
Study 34438022 — intervention group
Group type: EXPERIMENTAL
Intervention: Aggression
Number of subjects: 195
Study 34438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Inference Task (DIT) with high nonemotional inference
Number of subjects: 51
Study 34438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Inference Task (DIT) with emotional presence in high-inference condition
Number of subjects: 51
Study 34438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Inference Task (DIT) with low inference
Number of subjects: 51
Study 34438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Inference Task (DIT) with nonemotional presence
Number of subjects: 51
Study 34438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Inference Task (DIT) with direct gaze
Number of subjects: 51
Study 34438254 — intervention group
Group type: EXPERIMENTAL
Intervention: Dynamic Inference Task (DIT) with averted gaze
Number of subjects: 51
Study 34438333 — intervention group
Group type: EXPERIMENTAL
Intervention: Paretic leg
Number of subjects: 42
Study 34438333 — intervention group
Group type: COMPARATOR
Intervention: Non-paretic leg
Number of subjects: 42
Study 34438449 — intervention group
Group type: EXPERIMENTAL
Intervention: AED delivery by drones
Number of subjects: 14
Study 34438449 — intervention group
Group type: COMPARATOR
Intervention: Test flights of AED delivery by drones
Number of subjects: 14
Study 34438469 — intervention group
Group type: COMPARATOR
Intervention: Low-dose colchicine
Number of subjects: 803
Study 34438469 — intervention group
Group type: COMPARATOR
Intervention: High-dose colchicine
Number of subjects: 803
Study 34438804 — intervention group
Group type: EXPERIMENTAL
Intervention: Pet ownership
Number of subjects: 162
Study 34438804 — intervention group
Group type: COMPARATOR
Intervention: No pet ownership (control)
Number of subjects: 162
Study 34439146 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT) delivered as planned (60Gy in 15 fractions of 4.0Gy)
Number of subjects: 6
Study 34439146 — intervention group
Group type: EXPERIMENTAL
Intervention: Stereotactic body radiation therapy (SBRT)
Number of subjects: 6
Study 34439152 — intervention group
Group type: EXPERIMENTAL
Intervention: Euclidean distance (Euc)
Number of subjects: 290
Study 34439152 — intervention group
Group type: EXPERIMENTAL
Intervention: Manhattan distance (Man)
Number of subjects: 290
Study 34439152 — intervention group
Group type: EXPERIMENTAL
Intervention: Tchebychev distance (Tch)
Number of subjects: 290
Study 34439152 — intervention group
Group type: EXPERIMENTAL
Intervention: Travelling Salesman Problem distance (TSP)
Number of subjects: 290
Study 34439152 — intervention group
Group type: EXPERIMENTAL
Intervention: High SDmax
Number of subjects: 290
Study 34439152 — intervention group
Group type: EXPERIMENTAL
Intervention: High SD_TSP
Number of subjects: 290
Study 34439167 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting-Mimicking Diet (FMD) administered every three weeks/once a month, average of 6.3 cycles/patient
Number of subjects: 90
Study 34439167 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting-Mimicking Diet (FMD)
Number of subjects: 90
Study 34439258 — intervention group
Group type: EXPERIMENTAL
Intervention: DEEPGENTM platform for cancer detection
Number of subjects: 675
Study 34439258 — intervention group
Group type: COMPARATOR
Intervention: Control group (individuals with no known malignancy)
Number of subjects: 675
Study 34439284 — intervention group
Group type: EXPERIMENTAL
Intervention: zPDX (zebrafish patient-derived xenograft) exposed to chemotherapy regimens
Number of subjects: 0
Study 34439284 — intervention group
Group type: COMPARATOR
Intervention: Non-Responder group
Number of subjects: 0
Study 34439284 — intervention group
Group type: COMPARATOR
Intervention: Responder group
Number of subjects: 0
Study 34439284 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 0
Study 34439518 — intervention group
Group type: EXPERIMENTAL
Intervention: Deferoxamine (DFO) 40-60 mg/Kg/day
Number of subjects: 0
Study 34439518 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 34440175 — intervention group
Group type: EXPERIMENTAL
Intervention: ABVD chemotherapy regimen (doxorubicin, bleomycin, vinblastine, and dacarbazine)
Number of subjects: 86
Study 34440175 — intervention group
Group type: EXPERIMENTAL
Intervention: Complete switch-off of cancer lesions and cardiac lighting
Number of subjects: 86
Study 34440175 — intervention group
Group type: EXPERIMENTAL
Intervention: Multivariate Cox regression analysis
Number of subjects: 86
Study 34440684 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 13
Study 34440684 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined HIIT with strength training (COM)
Number of subjects: 13
Study 34440710 — intervention group
Group type: EXPERIMENTAL
Intervention: BNT162b2 mRNA vaccine
Number of subjects: 283
Study 34441766 — intervention group
Group type: EXPERIMENTAL
Intervention: PCOS girls
Number of subjects: 96
Study 34441766 — intervention group
Group type: COMPARATOR
Intervention: Control group (without PCOS)
Number of subjects: 96
Study 34441840 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciclesonide (320 µg inhalation twice per day for 14 days)
Number of subjects: 61
Study 34441840 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 61
Study 34442202 — intervention group
Group type: EXPERIMENTAL
Intervention: Bright Light Therapy (BLT) sessions of 10,000 lux for 30 minutes, Monday through Friday, for 4 weeks.
Number of subjects: 100
Study 34442202 — intervention group
Group type: COMPARATOR
Intervention: Control group not specified.
Number of subjects: 100
Study 34442403 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention not specified
Number of subjects: 0
Study 34442445 — intervention group
Group type: EXPERIMENTAL
Intervention: Laser Doppler Flowmetry (LDF) applied to traumatised teeth
Number of subjects: 44
Study 34442445 — intervention group
Group type: COMPARATOR
Intervention: Control group (sound and healthy teeth)
Number of subjects: 44
Study 34444128 — intervention group
Group type: EXPERIMENTAL
Intervention: Night shift work
Number of subjects: 59
Study 34444128 — intervention group
Group type: COMPARATOR
Intervention: Day shift work
Number of subjects: 59
Study 34445916 — intervention group
Group type: EXPERIMENTAL
Intervention: pegcetacoplan
Number of subjects: 263
Study 34445916 — intervention group
Group type: COMPARATOR
Intervention: ravulizumab
Number of subjects: 263
Study 34446008 — intervention group
Group type: EXPERIMENTAL
Intervention: Public transport use (≥3 days/week)
Number of subjects: 8547
Study 34446008 — intervention group
Group type: EXPERIMENTAL
Intervention: Public transport use (≥6 days/week)
Number of subjects: 8547
Study 34446008 — intervention group
Group type: COMPARATOR
Intervention: Private transport mode
Number of subjects: 8547
Study 34446008 — intervention group
Group type: COMPARATOR
Intervention: Private transport use (≥6 days/week)
Number of subjects: 8547
Study 34446008 — intervention group
Group type: EXPERIMENTAL
Intervention: Men
Number of subjects: 8547
Study 34446008 — intervention group
Group type: EXPERIMENTAL
Intervention: Mixed and other ethnicity (Asian, Indigenous, Gypsy, and other)
Number of subjects: 8547
Study 34446008 — intervention group
Group type: EXPERIMENTAL
Intervention: High socioeconomic level and middle/high education level
Number of subjects: 8547
Study 34446044 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment for colorectal cancer
Number of subjects: 0
Study 34446089 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympathetic amplitude response
Number of subjects: 21
Study 34446089 — intervention group
Group type: EXPERIMENTAL
Intervention: Sympathetic responses
Number of subjects: 21
Study 34446089 — intervention group
Group type: EXPERIMENTAL
Intervention: Parasympathetic responses
Number of subjects: 21
Study 34446110 — intervention group
Group type: EXPERIMENTAL
Intervention: CPAP/O
Number of subjects: 0
Study 34446224 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraoperative renal desaturation (detected in 38 infants)
Number of subjects: 242
Study 34446224 — intervention group
Group type: COMPARATOR
Intervention: No intraoperative renal desaturation (matched group of 114 infants)
Number of subjects: 242
Study 34446224 — intervention group
Group type: EXPERIMENTAL
Intervention: Cumulative time of renal desaturation
Number of subjects: 242
Study 34446358 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time PCR with polyadenylic acid (poly[A])
Number of subjects: 0
Study 34446358 — intervention group
Group type: COMPARATOR
Intervention: Real-time PCR without poly(A)
Number of subjects: 0
Study 34446358 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time PCR tests performed on different days
Number of subjects: 0
Study 34446377 — intervention group
Group type: EXPERIMENTAL
Intervention: Otago Exercise Programme (OEP)
Number of subjects: 30
Study 34446378 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-surgical patients
Number of subjects: 273
Study 34446378 — intervention group
Group type: EXPERIMENTAL
Intervention: Charlson Comorbidity Index (CCI)
Number of subjects: 273
Study 34446378 — intervention group
Group type: EXPERIMENTAL
Intervention: American Association of Anesthesiologists class
Number of subjects: 273
Study 34446378 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired daily functioning
Number of subjects: 273
Study 34446378 — intervention group
Group type: EXPERIMENTAL
Intervention: Dependent living
Number of subjects: 273
Study 34446378 — intervention group
Group type: EXPERIMENTAL
Intervention: Major postoperative complication in surgical patients
Number of subjects: 273
Study 34446577 — intervention group
Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemoimmunotherapy
Number of subjects: 46